Drugmakers take unorthodox route to boosting biosimilars

Sandoz worked with NHS on ‘copycat’ drug despite risk of no quick commercial return
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals